Name: Meningitis Vaccines Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1531
Price: 4350 USD
Availability: InStock

Meningitis Vaccines Market Size Share Growth Opportunities and Forecast 2022

Meningitis Vaccines Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Meningitis Vaccines Market is segmented&nbsp;By Vaccine Type (Meningococcal Conjugate Vaccine, Serogroup B Meningococcal Vaccine, Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine, Hemophilus Influenzae Type B (Hib) Vaccine),&nbsp;By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global Meningitis Vaccines Market is expected to grow at a high <a href="https://www.datamintelligence.com/download-sample/meningitis-vaccines-market">CAGR of 9.6%</a> during the forecasting period (2022-2029).
</blockquote>

<h2>Why purchase the report?</h2>

<ul>
	<li>
	Visualize the composition of the Meningitis Vaccines Market across each indication, regarding type and application highlighting the critical commercial assets and players.
	</li>
	<li>
	Identify business opportunities in Meningitis Vaccines Market by analyzing trends and co-development deals.
	</li>
	<li>
	Excel data sheet with thousands of data points of the Meningitis Vaccines Market levels 4/5 segmentation.
	</li>
	<li>
	PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
	</li>
	<li>
	Product mapping in excel for the essential Meningitis Vaccines Market of all major market players.
	</li>
</ul>

<h2>Who can benefit from this report?</h2>

<ul>
	<li>
	Raw Material Suppliers/ Buyers
	</li>
	<li>
	Product Suppliers/ Buyers
	</li>
	<li>
	Industry Investors/Investment Bankers
	</li>
	<li>
	<a href="https://www.datamintelligence.com/enquiry/meningitis-vaccines-market">Education &amp; Research Institutes</a>
	</li>
	<li>
	Research Professionals
	</li>
	<li>
	Emerging Companies
	</li>
	<li>
	Manufacturers
	</li>
</ul>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics:</h3>

<a href="https://www.datamintelligence.com/research-report/rnai-therapeutics-market">RNAi Therapeutics Market</a>

<a href="https://www.datamintelligence.com/research-report/chitosan-derivatives-market">Chitosan Derivatives Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>
		Market Snippet by Vaccine Type
		</li>
		<li>
		Market Snippet by End User
		</li>
		<li>
		Market Snippet by Region
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Technological advancements
				</li>
				<li>
				Rise in government initiatives
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				Stringent government regulations
				</li>
				<li>
				Lack of supply of vaccines
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis&nbsp;</h3>

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	<h3>Pipeline Analysis&nbsp;</h3>
	</li>
	<li>
	<h3>By Vaccine Type</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Attractiveness Index, By Vaccine Type
			</li>
		</ol>
		</li>
		<li>
		Meningococcal Conjugate Vaccine

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Serogroup B Meningococcal Vaccine
		</li>
		<li>
		Pneumococcal Conjugate Vaccine
		</li>
		<li>
		Pneumococcal Polysaccharide Vaccine
		</li>
		<li>
		Hemophilus Influenzae Type B (Hib) Vaccine
		</li>
	</ol>
	</li>
	<li>
	<h3>By End User</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User&nbsp;
			</li>
			<li>
			Market Attractiveness Index, By End User
			</li>
		</ol>
		</li>
		<li>
		Hospitals

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028
			</li>
		</ol>
		</li>
		<li>
		Clinics
		</li>
		<li>
		Ambulatory Surgical Centers
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia-Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Vaccine Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Meningitis Vaccines Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>
		Sanofi Pasteur SA *

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		GlaxoSmithKline Plc
		</li>
		<li>
		Pfizer Inc.
		</li>
		<li>
		Merck &amp; Co., Inc.
		</li>
		<li>
		Janssen Pharmaceuticals Inc.
		</li>
		<li>
		Panacea Biotec Limited
		</li>
		<li>
		Hualan Biological Engineering Inc.
		</li>
		<li>
		Serum Institute of India Pvt. Ltd.
		</li>
		<li>
		Baxter International Inc.
		</li>
		<li>
		Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.
		</li>
		<li>
		Beijing Tiantan Biological Products Corporation
		</li>
		<li>
		Novartis AG
		</li>
	</ol>
	</li>
	<li>
	<h3>Premium Insights</h3>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

&nbsp;List of Tables

Table 1 Global Meningitis Vaccines Market Value, By Vaccine Type, 2021,2025 &amp; 2029 ($ Million)

Table 2 Global Meningitis Vaccines Market Value, By End User, 2021,2025 &amp; 2029 ($ Million)

Table 3 Global Meningitis Vaccines Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 4 Global Meningitis Vaccines Market Value, By Vaccine Type, 2021,2025 &amp; 2029 ($ Million)

Table 5 Global Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 6 Global Meningitis Vaccines Market Value, By End User, 2021,2025 &amp; 2029 ($ Million)

Table 7 Global Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 8 Global Meningitis Vaccines Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 9 Global Meningitis Vaccines Market Value, By Region, 2017-2028 ($ Million)

Table 10 North America Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 11 North America Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 12 North America Meningitis Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 13 South America Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 14 South America Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 15 South America Meningitis Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 16 Europe Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 17 Europe Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 18 Europe Meningitis Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 19 Asia-Pacific Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 20 Asia-Pacific Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 21 Asia-Pacific Meningitis Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 22 Middle East &amp; Africa Meningitis Vaccines Market Value, By Vaccine Type, 2017-2028 ($ Million)

Table 23 Middle East &amp; Africa Meningitis Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 24 Sanofi Pasteur SA: Overview

Table 25 Sanofi Pasteur SA: Product Portfolio

Table 26 Sanofi Pasteur SA: Key Developments

Table 27 GlaxoSmithKline Plc: Overview

Table 28 GlaxoSmithKline Plc: Product Portfolio

Table 29 GlaxoSmithKline Plc: Key Developments

Table 30 Pfizer Inc.: Overview

Table 31 Pfizer Inc.: Product Portfolio

Table 32 Pfizer Inc.: Key Developments

Table 33 Merck &amp; Co., Inc.: Overview

Table 34 Merck &amp; Co., Inc.: Product Portfolio

Table 35 Merck &amp; Co., Inc.: Key Developments

Table 36 Janssen Pharmaceuticals Inc.: Overview

Table 37 Janssen Pharmaceuticals Inc.: Product Portfolio

Table 38 Janssen Pharmaceuticals Inc.: Key Developments

Table 39 Panacea Biotec Limited: Overview

Table 40 Panacea Biotec Limited: Product Portfolio

Table 41 Panacea Biotec Limited: Key Developments

Table 42 Hualan Biological Engineering Inc.: Overview

Table 43 Hualan Biological Engineering Inc.: Product Portfolio

Table 44 Hualan Biological Engineering Inc.: Key Developments

Table 45 Serum Institute of India Pvt. Ltd.: Overview

Table 46 Serum Institute of India Pvt. Ltd.: Product Portfolio

Table 47 Serum Institute of India Pvt. Ltd.: Key Developments

Table 48 Baxter International Inc.: Overview

Table 49 Baxter International Inc.: Product Portfolio

Table 50 Baxter International Inc.: Key Developments

Table 51 Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.: Overview

Table 52 Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.: Product Portfolio

Table 53 Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.: Key Developments

&nbsp;

List of Figures

Figure 1 Global Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 2 Global Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 3 Global Meningitis Vaccines Market Share, By Region, 2018 &amp; 2028 (%)

Figure 4 Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 5 Global Meningitis Vaccines Market Y-o-Y Growth, By Vaccine Type, 2018-2028 (%)

Figure 6 Meningococcal Conjugate Vaccine: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 7 Serogroup B Meningococcal Vaccine: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 8 Pneumococcal Conjugate Vaccine: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 9 Pneumococcal Polysaccharide Vaccine: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 10 Hemophilus Influenzae Type B (Hib) Vaccine: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 11 Global Meningitis Vaccines Market Y-o-Y Growth, By End User, 2018-2028 (%)

Figure 12 Hospitals: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 13 Clinics: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 14 Ambulatory Surgical Centers: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 15 Others: Global Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 16 Global Meningitis Vaccines Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 17 North America Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 18 North America Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 19 North America Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 20 North America Meningitis Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 21 South America Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 22 South America Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 23 South America Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 24 South America Meningitis Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 25 Europe Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 26 Europe Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 27 Europe Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 28 Europe Meningitis Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 29 Asia-Pacific Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 30 Asia-Pacific Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 31 Asia-Pacific Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 32 Asia-Pacific Meningitis Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 33 Middle East &amp; Africa Meningitis Vaccines Market Value, 2017-2028 ($ Million)

Figure 34 Middle East &amp; Africa Meningitis Vaccines Market Share, By Vaccine Type, 2018 &amp; 2028 (%)

Figure 35 Middle East &amp; Africa Meningitis Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 36 Sanofi Pasteur SA: Financials

Figure 37 GlaxoSmithKline Plc: Financials

Figure 38 Pfizer Inc.: Financials

Figure 39 Merck &amp; Co., Inc.: Financials

Figure 40 Janssen Pharmaceuticals Inc.: Financials

Figure 41 Panacea Biotec Limited: Financials

Figure 42 Hualan Biological Engineering Inc.: Financials

Figure 43 Serum Institute of India Pvt. Ltd.: Financials

Figure 44 Baxter International Inc.: Financials

Figure 45 Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.: Financial